News Releases
Monday, August 28, 2017
Designing Novel Biologic Agents to Target Colorectal CancerFriday, October 14, 2016
Long-Term Experience Supports Efficacy and Safety of PRRT for Treating Neuroendocrine TumorsTuesday, May 10, 2016
Long-Term Survival Achieved in Metastatic Melanoma With Personalized VaccineMonday, April 6, 2015
Can Cancer Vaccines Prolong Survival?Monday, November 12, 2012
Can the Addition of Radiolabeled Treatments Improve Outcomes in Advanced Metastatic Disease?Thursday, July 26, 2012
Should High-Dose Interleukin-2 Continue to be the Treatment of Choice for Metastatic Melanoma?Wednesday, February 15, 2012
Promising Early Results with Therapeutic Cancer Vaccines
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.
